Search Reset All Therapy AreasAge-Related Macular DegenerationAsthmaBreast CancerCardiovascularHodgkin’s LymphomaMalignant MelanomaMigraineMultiple MyelomaMultiple SclerosisNeurologyNon-Hodgkin's Lymphoma and Chronic Lymphocytic LeukemiaOncologyOphthalmologyOsteoarthritic PainOsteoarthritisParkinson's DiseasePsoriasisPsoriatic ArthritisRheumatoid ArthritisUlcerative Colitis All ProductsBiosimilarsChina In-DepthCurrent TreatmentEmerging TherapiesEpidemiologyProductSpecial Topics / OtherTreatment Algorithms: Claims Data AnalysisUnmet Need All GeographyChileUS All Years20222020201920182017201620152014 Previous12345Next May 10, 2019 Asthma & Chronic Obstructive Pulmonary Disorder | Emerging Therapies | Salmeterol/Fluticasone Generic | US | Wave 1 | 2019 February 22, 2019 Psoriatic Arthritis | Emerging Therapies | Xeljanz (tofacitinib) | US | Wave 3 | 2019 February 8, 2019 Rheumatoid Arthritis | Emerging Therapies | Olumiant (baricitinib) | US | Wave 2 | 2019 February 5, 2019 Asthma | Emerging Therapies | Dupixent (Dupilumab) | US | Wave 1 | 2019 February 4, 2019 Ulcerative Colitis | Emerging Therapies | Xeljanz (Tofacitinib) | US | Wave 2 | 2019 January 22, 2019 Migraine | Emerging Therapies | Aimovig | US | Wave 2 | 2019 December 21, 2018 Migraine | Emerging Therapies | Migraine Prophylaxis | Emgality and Ajovy | US | Wave 1 | 2018 December 7, 2018 Chimeric Antigen Receptor (CAR) T-Cell Therapy – Emerging Therapies – Chimeric Antigen (CAR) T-Cell Therapy – Special Topics – US (Wave 3) MARKET OUTLOOKThe accelerated approvals of Kymriah (Novartis) for the treatment of children and young adults with relapsed/refractory B-cell acute lymphoblastic leukemia (ALL) and Yescarta (Kite… September 24, 2018 Ulcerative Colitis | Emerging Therapies | Xeljanz (tofacitinib) | US | Wave 1 | 2018 September 21, 2018 Psoriasis | Emerging Therapies | Tremfya (IL-23) (guselkumab) | Wave 3 | US | 2018 September 21, 2018 Rheumatoid Arthritis | Emerging Therapies | Olumiant (baricitinib) | US | Wave 1 | 2018 August 22, 2018 Psoriatic Arthritis | Emerging Therapies | Xeljanz (tofacitinib) | US | Wave 2 | 2018 August 17, 2018 Migraine | Emerging Therapies | Migraine Prophylaxis | Erenumab-Migraine Prevention | US | Wave 1 | 2018 July 26, 2018 Multiple Sclerosis (Primary Progressive) | Emerging Therapies | Ocrevus (ocrelizumab) | Wave 3 | US | 2018 July 11, 2018 Multiple Sclerosis (Relapsing-Remitting) | Emerging Therapies | Ocrevus (ocrelizumab) | US | Wave 3 | 2018 Previous12345Next